Pharmaids Pharmaceuticals (PHARMAID) Shareholding Pattern

NSE: PHARMAID • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 32.99%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 47.02%
Total Shareholders 8,027
As of Sept 2025
View the latest shareholding pattern of Pharmaids Pharmaceuticals (PHARMAID) including promoter, FII, DII, and public holdings. Track PHARMAID ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Pharmaids Pharmaceuticals dividend payments)

Pharmaids Pharmaceuticals (PHARMAID) Shareholding Summary

  • Promoters have increased holding from 5.14% to 32.99% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has increased from 36.35% to 47.02% in Sept 2025
  • Number of shareholders increased from 8,026 to 8,027 in Sept 2025

PHARMAID Quarterly Ownership Changes

Quarter-over-quarter changes for Pharmaids Pharmaceuticals from Jun 2025 to Sept 2025.

Promoter Holding Change
Jun 2025 to Sept 2025
+27.85%
FII Holding Change
Jun 2025 to Sept 2025
No Change
DII Holding Change
Jun 2025 to Sept 2025
No Change
Public Holding Change
Jun 2025 to Sept 2025
+10.67%

Pharmaids Pharmaceuticals (PHARMAID) Quarterly Shareholding Trends

Visual breakdown of PHARMAID ownership distribution over time. Learn more about Pharmaids Pharmaceuticals financial data.

Promoter
FII
DII
Public
Government

Rising institutional holdings in PHARMAID often correlate with improved fundamentals. Check out PHARMAID fair price.

Pharmaids Pharmaceuticals (PHARMAID) Shareholding Data

Download complete PHARMAID ownership data for offline analysis. Discover PHARMAID investment value.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 32.99% 0.00% 0.00% 0.00% 47.02% 19.99% 100.00% 8,027
Jun 2025 5.14% 0.00% 0.00% 0.00% 36.35% 58.51% 100.00% 8,026
Mar 2025 5.22% 0.00% 0.00% 0.00% 36.59% 58.20% 100.01% 8,220
Dec 2024 5.22% 0.00% 0.00% 0.00% 36.42% 58.37% 100.01% 8,349
Sept 2024 5.19% 0.00% 0.00% 0.00% 41.03% 53.78% 100.00% 8,050
Jun 2024 5.56% 0.00% 0.00% 0.00% 41.14% 53.29% 99.99% 7,594
Apr 2024 5.64% 0.00% 0.00% 0.00% 41.06% 53.30% 100.00% 7,567
Mar 2024 5.64% 0.00% 0.00% 0.00% 41.06% 53.30% 100.00% 7,554
Dec 2023 9.25% 0.00% 0.00% 0.00% 60.78% 29.96% 99.99% 7,281
Sept 2023 9.70% 0.00% 0.00% 0.00% 81.93% 8.37% 100.00% 7,393
Jun 2023 9.94% 0.00% 0.00% 0.00% 81.27% 8.79% 100.00% 7,476
Mar 2023 9.95% 0.00% 0.00% 0.00% 81.71% 8.34% 100.00% 7,761
Dec 2022 16.54% 0.00% 0.00% 0.00% 69.78% 13.68% 100.00% 8,862
Sept 2022 21.08% 0.00% 0.00% 0.00% 74.07% 4.84% 99.99% 9,193
Jun 2022 20.70% 0.00% 0.00% 0.00% 78.72% 0.57% 99.99% 9,495
Mar 2022 35.44% 0.00% 0.00% 0.00% 63.98% 0.58% 100.00% 9,620
Jan 2022 16.45% 0.00% 0.00% 0.00% 69.87% 13.68% 100.00% 8,196
Dec 2021 55.56% 0.00% 0.00% 0.00% 43.47% 0.97% 100.00% 8,314
Sept 2021 65.65% 0.00% 0.00% 0.00% 33.70% 0.65% 100.00% 7,331
Jun 2021 65.80% 0.00% 0.00% 0.00% 33.19% 1.01% 100.00% 7,192
Mar 2021 65.81% 0.00% 0.00% 0.00% 33.44% 0.74% 99.99% 5,861

PHARMAID promoter holding above 50% indicates strong insider confidence. Explore the PHARMAID stock price history for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 32.99% 0.00% 0.00% 0.00% 47.02% 19.99% 100.00% 8,027
Jun 2025 5.14% 0.00% 0.00% 0.00% 36.35% 58.51% 100.00% 8,026
Mar 2025 5.22% 0.00% 0.00% 0.00% 36.59% 58.20% 100.01% 8,220
Dec 2024 5.22% 0.00% 0.00% 0.00% 36.42% 58.37% 100.01% 8,349
Sept 2024 5.19% 0.00% 0.00% 0.00% 41.03% 53.78% 100.00% 8,050
Jun 2024 5.56% 0.00% 0.00% 0.00% 41.14% 53.29% 99.99% 7,594
Apr 2024 5.64% 0.00% 0.00% 0.00% 41.06% 53.30% 100.00% 7,567
Mar 2024 5.64% 0.00% 0.00% 0.00% 41.06% 53.30% 100.00% 7,554
Dec 2023 9.25% 0.00% 0.00% 0.00% 60.78% 29.96% 99.99% 7,281
Sept 2023 9.70% 0.00% 0.00% 0.00% 81.93% 8.37% 100.00% 7,393
Jun 2023 9.94% 0.00% 0.00% 0.00% 81.27% 8.79% 100.00% 7,476
Mar 2023 9.95% 0.00% 0.00% 0.00% 81.71% 8.34% 100.00% 7,761

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 5.22% 0.00% 0.00% 0.00% 36.59% 58.20% 100.01% 8,220
Dec 2024 5.22% 0.00% 0.00% 0.00% 36.42% 58.37% 100.01% 8,349
Dec 2023 9.25% 0.00% 0.00% 0.00% 60.78% 29.96% 99.99% 7,281
Dec 2022 16.54% 0.00% 0.00% 0.00% 69.78% 13.68% 100.00% 8,862
Dec 2021 55.56% 0.00% 0.00% 0.00% 43.47% 0.97% 100.00% 8,314

Year-over-year trends reveal long-term ownership shifts.

Understanding Pharmaids Pharmaceuticals (PHARMAID) Shareholding Pattern

Pharmaids Pharmaceuticals shareholding pattern reveals who owns PHARMAID stock and how ownership changes over time. High promoter stakes in PHARMAID often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your PHARMAID trades. Pharmaids Pharmaceuticals quarterly financials

Combine PHARMAID ownership analysis with price movements and financial performance for a complete investment picture. (See PHARMAID annual price range)